SURMODICS INC Quarterly Deferred Income Tax Expense (Benefit) in USD from Q4 2010 to Q4 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Surmodics Inc annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from Q4 2010 to Q4 2023.
- Surmodics Inc Deferred Income Tax Expense (Benefit) for the quarter ending December 31, 2023 was -$97K, a 9.35% increase year-over-year.
- Surmodics Inc annual Deferred Income Tax Expense (Benefit) for 2024 was -$320K, a 76.8% decline from 2023.
- Surmodics Inc annual Deferred Income Tax Expense (Benefit) for 2023 was -$181K, a 103% decline from 2022.
- Surmodics Inc annual Deferred Income Tax Expense (Benefit) for 2022 was $5.27M, a 219% increase from 2021.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)